We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$14.5M
Cap. Flow
-$16.8M
Cap. Flow %
-15.73%
Top 10 Hldgs %
2.69%
Holding
2,904
New
705
Increased
558
Reduced
830
Closed
739

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$423K
2
GIS icon
General Mills
GIS
+$314K
3
MO icon
Altria Group
MO
+$234K
4
PX
Praxair Inc
PX
+$231K
5
ATR icon
AptarGroup
ATR
+$231K

Sector Composition

Rank Sector Weight
1 Industrials 15.12%
2 Healthcare 14.17%
3 Financials 13.11%
4 Consumer Discretionary 12.41%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTIV
2076
DELISTED
OTI On Track Innovations Ltd
OTIV
$2K ﹤0.01%
+1,264
New +$1.78K
IGLD
2077
DELISTED
Internet Gold-Golden Lines Ltd
IGLD
$2K ﹤0.01%
2
OAKS
2078
DELISTED
Five Oaks Investment Corp.
OAKS
$2K ﹤0.01%
+326
New +$1.72K
ACTA
2079
DELISTED
Actua Corp
ACTA
$2K ﹤0.01%
119
-1,980
-94% -$27.9K
WPG
2080
DELISTED
Washington Prime Group Inc.
WPG
$2K ﹤0.01%
32
-286
-90% -$21.5K
AFMD
2081
DELISTED
Affimed
AFMD
$1K ﹤0.01%
66
-354
-84% -$7.86K
CECO icon
2082
Ceco Environmental
CECO
$4.11B
$1K ﹤0.01%
62
-23,091
-100% -$233K
CIG icon
2083
CEMIG Preferred Shares
CIG
$5.84B
$1K ﹤0.01%
589
-1,177
-67% -$1.56K
CSPI icon
2084
CSP Inc
CSPI
$81.6M
$1K ﹤0.01%
254
-9,226
-97% -$49.5K
CYTK icon
2085
Cytokinetics
CYTK
$10.5B
$1K ﹤0.01%
81
-1,397
-95% -$19.4K
CZNC icon
2086
Citizens & Northern Corp
CZNC
$454M
$1K ﹤0.01%
+22
New +$509
DAC icon
2087
Danaos Corp
DAC
$2.52B
$1K ﹤0.01%
28
-1,606
-98% -$34.9K
DCOM icon
2088
Dime Commercial Bancshares
DCOM
$1.77B
$1K ﹤0.01%
22
-585
-96% -$20K
FDUS icon
2089
Fidus Investment
FDUS
$753M
$1K ﹤0.01%
+61
New +$1.05K
FPI
2090
Farmland Partners
FPI
$424M
$1K ﹤0.01%
+118
New +$1.2K
LKFT
2091
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$1K ﹤0.01%
7
GSBD icon
2092
Goldman Sachs BDC
GSBD
$1.1B
$1K ﹤0.01%
+27
New +$635
GSL icon
2093
Global Ship Lease
GSL
$1.51B
$1K ﹤0.01%
127
-3,037
-96% -$31.5K
HOPE icon
2094
Hope Bancorp
HOPE
$1.79B
$1K ﹤0.01%
+57
New +$1.06K
HTGC icon
2095
Hercules Capital
HTGC
$3.21B
$1K ﹤0.01%
+95
New +$1.32K
KGC icon
2096
Kinross Gold
KGC
$32.5B
$1K ﹤0.01%
219
-22,100
-99% -$87.9K
KKR icon
2097
KKR & Co
KKR
$93.2B
$1K ﹤0.01%
+42
New +$769
LRFC
2098
DELISTED
Logan Ridge Finance Corp
LRFC
$1K ﹤0.01%
7
-216
-97% -$17.8K
MITT
2099
TPG Mortgage Investment Trust
MITT
$201M
$1K ﹤0.01%
+24
New +$1.34K
MYGN icon
2100
Myriad Genetics
MYGN
$311M
$1K ﹤0.01%
47
-500
-91% -$10.6K

Similar funds

Acrospire Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Acrospire Investment Management held 2,904 positions worth $107M, down 12% from $121M the previous quarter. Its ten largest holdings account for 2.7% of the portfolio.

Acrospire Investment Management withdrew a net $16.8M in Q2 2017, closing 739 positions and reducing 830 holdings. Its most notable exit was Bunge Global, an estimated $285K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Acrospire Investment Management opened a new position in Procter & Gamble worth $418K.

  • Acrospire Investment Management's largest Q2 2017 buy was Procter & Gamble: 4,800 shares worth $418K.
  • Acrospire Investment Management added most to General Mills in Q2 2017, an estimated $314K increase.
  • Acrospire Investment Management's biggest Q2 2017 reduction was Navios Maritime Acquisition Corporation, cutting an estimated $1.35M.
  • Acrospire Investment Management fully exited Bunge Global in Q2 2017, selling an estimated $285K.
  • Acrospire Investment Management's ten largest holdings make up 2.7% of its $107M portfolio in Q2 2017.
  • Acrospire Investment Management opened 705 new positions and closed 739 in Q2 2017.
  • Acrospire Investment Management's portfolio value fell 12% quarter-over-quarter to $107M.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.